acyclovir triphosphate

Known as: 9-(2-hydroxyethoxymethyl)guanine triphosphate, triphosphoric acid, P-(2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl) ester 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2017
012319802017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The antiviral drug acyclovir is a guanosine nucleoside analog that potently inhibits herpes simplex virus (HSV) replication… (More)
Is this relevant?
1996
1996
Immunocompromised patients are frequently treated with guanine analogs such as acyclovir and ganciclovir. Acyclovir triphosphate… (More)
Is this relevant?
1992
1992
Expression of the human cytomegalovirus (HCMV) (AD169) DNA polymerase gene under the control of the polyhedrin promoter of… (More)
Is this relevant?
1989
1989
Acyclovir triphosphate (ACVTP) was a substrate for herpes simplex virus type 1 (HSV-1) DNA polymerase and was rapidly… (More)
Is this relevant?
1989
1989
The ability of herpes simplex virus type 1 (HSV-1) DNA polymerase, HeLa polymerase alpha, and HeLa polymerase beta to utilize… (More)
  • figure 1
  • table I
  • table 111
  • table 11
  • figure 2
Is this relevant?
1985
1985
The antiherpes agent 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) is a much more potent inhibitor of herpes simplex viruses in… (More)
Is this relevant?
1981
1981
The biochemical properties of four acyclovir-resistant mutants are described. Two of these mutants, PAAr5 and BWr, specified… (More)
Is this relevant?
1981
1981
The inhibition of highly purified herpes simplex virus (HSV)-induced and host cell DNA polymerases by the triphosphate form of 9… (More)
Is this relevant?
1980
1980
Acyclovir [9-(2-hydroxyethoxymethyl)guanine] triphosphate inhibits Epstein-Barr virus (EBV)-associated DNA polymerase (DNA… (More)
Is this relevant?
1980
1980
The effect of the triphosphate of 9-(2-hydroxyethoxymethyl)guanine (acyclovir, acycloguanosine) on cellular alpha… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?